Development of prognostic predictive model with neutrophil-lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma

被引:5
|
作者
Yang, Shihai [1 ]
Li, Shangdong [1 ]
机构
[1] Inner Mongolia Med Univ, Neimenggu Baogang Hosp, Dept Surg Oncol, Baotou 014040, Peoples R China
关键词
GSRC; neutrophil-lymphocyte ratio; prognosis; PREOPERATIVE NEUTROPHIL; CANCER; SURVIVAL; ADENOCARCINOMA; EXPRESSION; CYTOKINES; CELLS;
D O I
10.1097/MD.0000000000028043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk factors have not been well-defined for prognosis in gastric signet ring cell carcinoma (GSRC) patients. This study is designed to prognosticate survival in GSRC patients by establishing and verifying a predictive model with neutrophil-lymphocyte ratio (NLR). A total of 147 GSRC patients from Department of Surgical Oncology, Neimenggu Baogang Hospital, Inner Mongolia Medical University were retrospectively reviewed. A predictive model was established using Cox proportional hazards. The performance of the model was evaluated by ROC curves. In present study, we found that overall survival (OS) (P < .001, Fig. 1A) and tumor recurrence rate (P= .036, Fig. 1B) in the NLR < 2.8 group were significantly better than those in the NLR > 2.8 group. These results showed that NLR < 2.8 was significant prognostic factor related with both OS and tumor recurrence in patients with GSRC. After adjusting for competing risk factors, NLR < 2.8 (hazard ratio [HR]: 2.625, 95% confidence interval [CI]: 1.505-5.3166, P = .003), tumor size (HR: 3.024, 95% CI: 1.521-4.186, P = .005), and tumor metastasis (HR: 3.303, 95% CI: 1.25-4.525, P= .012) remained independent predictors of tumor recurrence rate and OS. Our results showed that comparing with the model without NLR (area under ROC curve: 0.798), the model with NLR (area under ROC curve: 0.826) had significant better predictive power than the model without NLR, which further confirmed the value of NLR in predicting prognosis of patients with GSRC. In conclusion, a high NLR value independently predicts poor survival in patients with GSRC after surgery. The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy in order to choose alternative therapies for patients with high NLR value.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Pretreament neutrophil-lymphocyte ratio (NLR): A felicitous prognostic marker in carcinoma lung
    Sehgal, Shailley A.
    Malik, Garima
    Sachdeva, Aman
    Chauhan, Ashok K.
    Kaushal, Vivek
    Kaur, Paramjeet
    Atri, Rajeev
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S719 - S723
  • [2] Pretreament neutrophil-lymphocyte ratio (NLR): A felicitous prognostic marker in carcinoma lung
    Sehgal, Shailley A.
    Malik, Garima
    Sachdeva, Aman
    Chauhan, Ashok K.
    Kaushal, Vivek
    Kaur, Paramjeet
    Atri, Rajeev
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S719 - S723
  • [3] THE PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL-LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH COVID-19
    Ahsan, Muhammad
    Gandhi, Krupa
    Kurpad, Krishna
    Bayambe, Santhosh
    Kulkarni, Rohit
    Maharaul, Mashrutee
    Nair, Archana Sreekantan
    Gopal, Shwetha
    Kumar, Vikash
    Mehta, Harsh
    Rezai, Fariborz
    Yodice, Paul
    Fless, Kristin
    Ovnanian, Vagram
    Safford, Mark
    Mistry, Nirav
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 89 - 89
  • [4] Prognostic implications of baseline neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in metastatic gastric cancer (GC) patients
    Petrillo, A.
    Laterza, M. M.
    Ventriglia, J.
    Savastano, B.
    Tirino, G.
    Pompella, L.
    Martinelli, E.
    Morgillo, F.
    Orditura, M.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Is the neutrophil-lymphocyte ratio (NLR) a predictive and prognostic factor in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT)?
    Shin, Ui Sup
    You, Y. Nancy
    Price, Brandee A.
    Rodriguez-Bigas, Miguel A.
    Skibber, John Michael
    Maru, Dipen M.
    Taggart, Melissa W.
    Kopetz, Scott
    Eng, Cathy
    Minsky, Bruce D.
    Das, Prajnan
    Krishnan, Sunil
    Chang, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] The Prognostic Value of the Neutrophil-Lymphocyte Ratio (NLR) in Acute Pancreatitis: Identification of an Optimal NLR
    Suppiah, Aravind
    Malde, Deep
    Arab, Tameem
    Hamed, Mazin
    Allgar, Victoria
    Smith, Andrew M.
    Morris-Stiff, Gareth
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (04) : 675 - 681
  • [7] Prognostic Value of the Prediagnostic Neutrophil-Lymphocyte Ratio (NLR) for the Survival of Patients With Lung Cancer
    Bar Ad, V.
    Lai, Y.
    Lu, B.
    Palmer, J.
    Myers, R.
    Ye, Z.
    Wang, C.
    Axelrod, R.
    Campling, B.
    Werner-Wasik, M.
    Cowan, S.
    Evans, N.
    Kumar, R.
    Hehn, B.
    Solomides, C.
    Yang, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S78 - S78
  • [8] Neutrophil-lymphocyte ratio (NLR) as a prognostic factor in metastatic breast cancer
    Ayala de la Pena, F.
    Yufera Soler, J. C.
    Ivars, M. A.
    Fernandez Sanchez, A.
    Navarro Manzano, E.
    De la Morena Barrio, P.
    Garcia-Garre, E.
    Garcia-Martinez, E.
    Marin Zafra, G.
    Salguero Aguilar, R.
    Garcia, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Predictive value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) In hepatocellular carcinoma (HCC) patients treated with nivolumab (N)
    Dharmapuri, S.
    Ozbek, U.
    Lin, J-Y.
    Schwartz, M.
    Branch, A.
    Ang, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Adrenocortical Carcinoma
    Solak, Mirsala
    Kraljevic, Ivana
    Zibar Tomsic, Karin
    Kastelan, Marko
    Kakarigi, Luka
    Kastelan, Darko
    ENDOCRINE RESEARCH, 2021, 46 (02) : 74 - 79